Eternal Life: Cell Immortalization and Tumorigenesis - PowerPoint PPT Presentation

About This Presentation
Title:

Eternal Life: Cell Immortalization and Tumorigenesis

Description:

Eternal Life: Cell Immortalization and Tumorigenesis neomycin-resistant gene was introduced into the midst of the telomeric DNA Exchange of sequence information ... – PowerPoint PPT presentation

Number of Views:738
Avg rating:3.0/5.0
Slides: 41
Provided by: bma127
Category:

less

Transcript and Presenter's Notes

Title: Eternal Life: Cell Immortalization and Tumorigenesis


1
Eternal Life Cell Immortalization and
Tumorigenesis
2
Normal cell populations register the number of
cell generations separating them from their
ancestors in the early embryo
  • Normal cells have a limited proliferative
    potential.
  • Cancer cells need to gain the ability to
    proliferate indefinitely immortal.
  • The immortality is a critical component of the
    neoplastic growth program.

3
Hayflick limit of Normal human cells
(Fibroblasts) in monolayer culture
  • They possess an intrinsically programmed limit
    (now known as the Hayflick limit) to their
    capacity for proliferation
  • even after a substantial healthy period of cell
    division, they undergo a permanent growth arrest
    (replicative senescence).

4
Cells need to become immortal in order to form
cancers
  • Two regulatory mechanisms to govern the
    replicative capacity of cells
  • Senescence
  • Cumulative physiologic stress over extended
    periods of time halts further proliferation.
  • These cells enter into a state of senescence.
  • Accumulation of oxidative damage contributes to
    senescence, e.g., reactive oxygen species (ROS),
    DNA damage
  • crisis
  • Cells have used up the allowed quota of
    replicative doublings. These cells enter into a
    state of crisis, which leads to apoptosis.

5
Replicative senescence in vitro
Proliferating human fibroblasts
  • Senescent cells in culture
  • fried egg morphology
  • Remain metabolically active, but lost the ability
    to re-enter into the active cell cycle
  • The downstream signaling pathways seem to be
    inactivated
  • Senescence associated ß-galactosidase (lysosomal
    ß-D-galactosidase)

6
Cell senescence does occur in vivo
Senescence-associated ß-galactosidase (SA-ß-gal)
Treatment of lung cancer with chemotherapeutic
drugs appear to induce senescence in tumor cells
7
Young and old keratinocytes in the skin
Keratinocyte stem cells in the skin lose
proliferative capacity with increasing age.
8
Cancer cells and embryonic stem cells share some
replicative properties
  • Embryonic stem (ES) cells show unlimited
    replicative potential in culture and are thus
    immortal.
  • The replicative behavior of cancer cells
    resembles that of ES cells.
  • Many types of cancer cells seem able to
    proliferate forever when provided with proper in
    vitro culture conditions
  • HeLa cells (Henrietta Lacks, 1951)
  • the 1st human cell line and 1st human cancer cell
    linen established in culture
  • derived from the tissue of cervical adenocarcinoma

9
  • cell cultures derived from human cancer tissues,
    once successfully established in vitro, are often
    immortal

10
Cell populations in crisis show widespread
apoptosis
11
The proliferation of cultured cells is limited by
the telomeres of their chromosomes
  • Barbara McClintoch discovered (1941) specialized
    structures at the ends of chromosomes, the
    telomeres, that protected chromosomes from
    end-to-end fusions.
  • She also demonstrated movable genetic elements in
    the corn genome, later called transposons
  • Nobel prize in Physiology Medicine in 1983

12
Telomeres detected by fluorescence in situ
hybridization (FISH)
telomeric DNA
13
  • Telomeric repeat-binding factor
  • Telomeric repeat-binding factor

The telomeres lose their protective function in
cells that have been deprived of TRF2, a key
protein in maintaining normal telomere structure.
In an extreme form, all the chromosomes of the
cell fused into one giant chromosome.
TRF2 Telomeric repeat-binding factor 2
14
Mechanisms of breakage-fusion-bridge cycles
2 sister chromatids during the G2 phase of the
cell cycle
15
truncation translocation aneuploidy
16
the end-replication problemTelomeric DNA
shortens progressively as cells divide
  • An inevitable consequence of semi-conservative
    DNA replication in eukaryotic cells
  • The free DNA ends of each chromosome are not
    duplicated completely by DNA polymerase.
  • Consequently, the ends of human chromosomes can
    lose up to 200 bp of DNA per cell division.

telomere shortening chromosomes fuse apoptotic
death
17
Primers and the initiation of DNA synthesis
this sequence is not replicated
18
Telomeres are complex molecular structures that
are not easily replicated
Telomeric DNA 5-TTAGGG-3 hexanucleotide
sequence, tandemly repeated thousands of times
19
Structure of the T-loop
  • The 3' DNA end at each telomere is always longer
    than the 5 end with which it is paired, leaving
    a protruding single-stranded
  • This protruding end has been shown to loop back
    and tuck its single stranded terminus into the
    duplex DNA of the telomeric repeat sequence to
    form a t-loop

20
  • T-loops provide the normal ends of chromosomes
    with a unique structure, which protects them from
    degradative enzymes and clearly distinguishes
    them from the ends of the broken DNA molecules
    that the cell rapidly repairs

21
Multiple telomere-specific proteins bound to
telomeric DNA
TRF Telomeric repeat-binding factor
22
Cancer cells can escape crisis by expressing
telomerase
  • Telomerase activity (elongate telomeric DNA)
  • Clearly detectable in 85 to 90 of human tumor
    cell samples
  • Present at very low levels in most types of
    normal human cells.
  • Telomerase holoenzyme
  • hTERT catalytic subunit
  • hTR RNA subunit
  • (At least 8 other subunits may exist in the
    holoenzyme but have not been characterized.)

23
human telomerase-associated RNA (template for
hTERT)
human telomerase reverse transcriptase
24
Oncoproteins and tumor suppressor proteins play
critical roles in governing hTERT expression
  • The mechanisms that lead to the de-repression of
    hTERT transcription during tumor progression in
    humans are complex and still quite obscure.
  • Multiple transcription factors appear to
    collaborate to activate the hTERT promoter.
  • For example, the Myc protein and Menin (the
    product of the MEN1 tumor suppressor gene),
    deregulate the cell clock.

25
Prevention of crisis by expression of telomerase
HEK human embryonic kidney cells
26
The role of telomeres in replicative senescence
  • In cultured human fibroblasts, senescence can be
    postponed by expressing hTERT prior to the
    expected time for entering replicative
    senescence.
  • However, senescence is also observed in cells
    that still possess quite long telomeres.
  • Why?

27
Possible explanations
  • When cells encounter cell-physiologic stress or
    the stress of tissue culture, telomeric DNA loses
    many of the single-stranded overhangs at the
    ends.
  • The resulting degraded telomeric ends may release
    a DNA damage signal, thereby provoking a
    p53-mediated halt in cell proliferation that is
    manifested as the senescent growth state

28
Replicative senescence and the actions of
telomerase
This is a still-speculative mechanistic model of
how and why telomerase expression can prevent
human cells from entering into replicative
senescence.
29
Telomerase plays a key role in the proliferation
of human cancer cell
  • Expression of antisense RNA in the telomerase ()
    HeLa cells
  • They stop growing 23 to 26 days.
  • Expression of the dominant negative hTERT subunit
    in telomerase () human tumor cell lines
  • They lose all detectable telomerase activity
  • with some delay, they enter crisis.

30
Suppression of telomerase results in the loss of
the neoplastic growth in 4 different human cancer
cell lines
(length of telomeric DNA at the onset of the
experiment)
31
Some immortalized cells can maintain telomeres
without telomerase
  • 85 to 90 of human tumors have been found to be
    telomerase-positive.
  • The remaining 10 to 15 lack detectable
    telomerase activity, yet they need to maintain
    their telomeres above some minimum length in
    order to proliferate indefinitely.
  • These cells obtain the ability to maintain their
    telomeric DNA using a mechanism that does not
    depend on the actions of telomerase.

32
  • the vast majority of the yeast Saccharomyces
    cervisiae cells enter a state of crisis and die
    following inactivation of genes encoding
    subunits of the telomerase holoenzyme.
  • Rare variants emerged from these populations of
    dying cells that used the alternative lengthening
    of telomerase (ALT) mechanism to construct and
    maintain their telomeres.
  • This ALT mechanism is also used by the minority
    of human tumor cells that lack significant
    telomerase activity, e.g., 50 osteosarcomas and
    soft-tissue sarcomas and many glioblastomas.

33
The ALT (alternative lengthening of telomerase )
mechanism (or copy-choice mechanism)
34
Exchange of sequence information between the
telomeres of different chromosomes
neomycin-resistant gene was introduced into the
midst of the telomeric DNA
35
Telomeres play different roles in the cells of
laboratory mice and in human cells
  • Rodent cells, especially those of the laboratory
    mouse strains, express significant levels of
    telomerase throughout life.
  • The double-stranded region of mouse telomeric DNA
    is as much as 30 to 40 kb long ( 5 times longer
    than corresponding human telomeric DNA).
  • Therefore, laboratory mice do not rely on
    telomere length to limit the replicative capacity
    of their normal cell lineages and that telomere
    erosion cannot serve as a mechanism for
    constraining tumor development in these rodents.

36
Long telomeres (in mice) do not
suffice for tumor formation
  • Transgenic mice expressing mTERT (mouse homolog
    of telomerase reverse transcriptase) contributes
    to tumorigenesis even though the mouse cells in
    which this enzyme acts already possess very long
    (gt30 kb) telomeres.
  • Thus, the mTERT enzyme aids tumorigenesis through
    mechanisms other than simple telomere extension.

37
- Mouse cells can be immortalized relatively
easily following extended propagation in culture.
- Human cells require, instead, the
introduction of both the SV40 large T oncogene
(to avoid senescence) and the hTERT gene (to
avoid crisis).
38
SV40 and T antigens
  • If the SV40 large T oncoprotein is expressed in
    human fibroblasts, these cells will continue to
    replicate another 10 to 20 cell generations and
    then enter crisis.
  • On rare occasion, a small propotion of cells (1
    out of 106 cells) will proceed to proliferate and
    continue to do indefinitely ? becoming
    immortalized.

39
SV40 the 40th simian virus in a series of
isolates papovavirus papilloma, polyoma
vacuolating agent
40
SV40 large T antigen can circumvent senescence
HEK human embryonic kidney cells
Write a Comment
User Comments (0)
About PowerShow.com